{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:03:39Z","timestamp":1771484619021,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005365","name":"Ehime University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009851","name":"Canon Foundation for Scientific Research","doi-asserted-by":"publisher","award":["0671-2020-0063"],"award-info":[{"award-number":["0671-2020-0063"]}],"id":[{"id":"10.13039\/100009851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H02527"],"award-info":[{"award-number":["19H02527"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmc.2021.116391","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T20:09:44Z","timestamp":1630181384000},"page":"116391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Inhibition of amyloid formation of amyloid \u03b2 (1\u201342), amylin and insulin by 1,5-diazacyclooctanes, a spermine-acrolein conjugate"],"prefix":"10.1016","volume":"46","author":[{"given":"Risako","family":"Kunitomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambara R.","family":"Pradipta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Lobsiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-5766","authenticated-orcid":false,"given":"Tamotsu","family":"Zako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116391_b0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J Mol Med"},{"key":"10.1016\/j.bmc.2021.116391_b0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein Misfolding, Functional Amyloid, and Human Disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmc.2021.116391_b0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"Soto","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmc.2021.116391_b0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2021.116391_b0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature20416","article-title":"The activities of amyloids from a structural perspective","volume":"539","author":"Riek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2021.116391_b0030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1152\/physrev.00006.2009","article-title":"Prions: Protein aggregation and infectious diseases","volume":"89","author":"Aguzzi","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmc.2021.116391_b0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2021.116391_b0040","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.chemrev.0c00981","article-title":"Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes","volume":"121","author":"Milardi","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2021.116391_b0045","doi-asserted-by":"crossref","first-page":"106507","DOI":"10.1016\/j.bpc.2020.106507","article-title":"Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology","volume":"269","author":"Ivanova","year":"2021","journal-title":"Biophys Chem"},{"key":"10.1016\/j.bmc.2021.116391_b0050","doi-asserted-by":"crossref","first-page":"106421","DOI":"10.1016\/j.bpc.2020.106421","article-title":"Structures of the intrinsically disordered A\u03b2, tau and \u03b1-synuclein proteins in aqueous solution from computer simulations","volume":"264","author":"Nguyen","year":"2020","journal-title":"Biophys Chem"},{"key":"10.1016\/j.bmc.2021.116391_b0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF00276849","article-title":"Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient","volume":"31","author":"Dische","year":"1988","journal-title":"Diabetologia"},{"key":"10.1016\/j.bmc.2021.116391_b0060","doi-asserted-by":"crossref","first-page":"37721","DOI":"10.1039\/D0RA07742A","article-title":"Insulin amyloid polymorphs: Implications for iatrogenic cytotoxicity","volume":"10","author":"Yuzu","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2021.116391_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-019-0385-0","article-title":"Toxicity of insulin-derived amyloidosis : a case report","volume":"19","author":"Iwaya","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.bmc.2021.116391_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86001-y","article-title":"Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates","volume":"11","author":"Mori","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116391_b0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0140-6736(09)60041-6","article-title":"The insulin ball","volume":"373","author":"Nagase","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116391_b0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: A case series","volume":"127","author":"Nagase","year":"2014","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.bmc.2021.116391_b0085","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1161\/01.STR.0000190004.36793.2d","article-title":"Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke","volume":"36","author":"Tomitori","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.bmc.2021.116391_b0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0197-4580(00)00235-9","article-title":"Acrolein is increased in Alzheimer\u2019s disease brain and is toxic to primary hippocampal cultures","volume":"22","author":"Lovell","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmc.2021.116391_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1507\/endocrj.50.61","article-title":"Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes","volume":"50","author":"Daimon","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/j.bmc.2021.116391_b0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0006-291X(03)00716-2","article-title":"Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients","volume":"305","author":"Sakata","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2021.116391_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200700412","article-title":"Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease","volume":"52","author":"Stevens","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.bmc.2021.116391_b0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2008.11.054","article-title":"Acrolein toxicity: Comparison with reactive oxygen species","volume":"378","author":"Yoshida","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2021.116391_b0115","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1073\/pnas.95.9.4882","article-title":"Protein-bound acrolein: Potential markers for oxidative stress","volume":"95","author":"Uchida","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2021.116391_b0120","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1039\/C4OB00761A","article-title":"Polyamine modification by acrolein exclusively produces 1,5-diazacyclooctanes: A previously unrecognized mechanism for acrolein-mediated oxidative stress","volume":"12","author":"Tsutsui","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2021.116391_b0125","doi-asserted-by":"crossref","first-page":"1600082","DOI":"10.1002\/advs.201600082","article-title":"1,5-Diazacyclooctanes, as Exclusive Oxidative Polyamine Metabolites, Inhibit Amyloid-\u03b2(1\u201340) Fibrillization","volume":"3","author":"Tsutsui","year":"2016","journal-title":"Adv Sci"},{"key":"10.1016\/j.bmc.2021.116391_b0130","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1021\/bi301705c","article-title":"Human prefoldin inhibits amyloid-\u03b2 (A\u03b2) fibrillation and contributes to formation of nontoxic A\u03b2 aggregates","volume":"52","author":"S\u00f6rgjerd","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2021.116391_b0135","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1021\/bi034868o","article-title":"Partially folded intermediates in insulin fibrillation","volume":"42","author":"Ahmad","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2021.116391_b0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cbic.200800762","article-title":"Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol","volume":"10","author":"Mishra","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2021.116391_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2021.116391_b0150","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","article-title":"Protein folding and aggregation into amyloid: The interference by natural phenolic compounds","volume":"14","author":"Stefani","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2021.116391_b0155","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10822-020-00311-3","article-title":"Resveratrol as a nontoxic excipient stabilizes insulin in a bioactive hexameric form","volume":"34","author":"Pathak","year":"2020","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2021.116391_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2046327","article-title":"Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives","volume":"2016","author":"Pithadia","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.bmc.2021.116391_b0165","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.bbamem.2018.03.012","article-title":"A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage","volume":"1860","author":"Sciacca","year":"2018","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10.1016\/j.bmc.2021.116391_b0170","doi-asserted-by":"crossref","unstructured":"R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, C.G. Glabel, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science (80-.). 300 (2003) 486\u2013489. https:\/\/doi.org\/10.1126\/science.1079469.","DOI":"10.1126\/science.1079469"},{"key":"10.1016\/j.bmc.2021.116391_b0175","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1111\/j.1742-4658.2010.07721.x","article-title":"Mysterious oligomerization of the amyloidogenic proteins","volume":"277","author":"Uversky","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2021.116391_b0180","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid oligomers: A joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2021.116391_b0185","doi-asserted-by":"crossref","first-page":"106505","DOI":"10.1016\/j.bpc.2020.106505","article-title":"Visualizing and trapping transient oligomers in amyloid assembly pathways","volume":"268","author":"Cawood","year":"2021","journal-title":"Biophys Chem"},{"key":"10.1016\/j.bmc.2021.116391_b0190","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1039\/C5CC07792C","article-title":"Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranes","volume":"52","author":"Pithadia","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2021.116391_b0195","doi-asserted-by":"crossref","first-page":"13129","DOI":"10.1039\/D0CC04803H","article-title":"Small molecule induced toxic human-IAPP species characterized by NMR","volume":"56","author":"Cox","year":"2020","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2021.116391_b0200","doi-asserted-by":"crossref","unstructured":"S.J. Cox, B. Lam, A. Prasad, H.A. Marietta, N.V. Stander, J.G. Joel, B.R. Sahoo, F. Guo, A.K. Stoddard, M.I. Ivanova, M.I. Ivanova, A. Ramamoorthy, High-Throughput Screening at the Membrane Interface Reveals Inhibitors of Amyloid-\u03b2, Biochemistry. 59 (2020) 2249\u20132258. https:\/\/doi.org\/10.1021\/acs.biochem.0c00328.","DOI":"10.1021\/acs.biochem.0c00328"},{"key":"10.1016\/j.bmc.2021.116391_b0205","doi-asserted-by":"crossref","first-page":"106480","DOI":"10.1016\/j.bpc.2020.106480","article-title":"Effect of tert-alcohol functional imidazolium salts on oligomerization and fibrillization of amyloid \u03b2 (1\u201342) peptide","volume":"267","author":"Said","year":"2020","journal-title":"Biophys Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:18:36Z","timestamp":1760836716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621003990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":41,"alternative-id":["S0968089621003990"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116391","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of amyloid formation of amyloid \u03b2 (1\u201342), amylin and insulin by 1,5-diazacyclooctanes, a spermine-acrolein conjugate","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116391"}}